Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

NCT00864331 is registered in ClinicalTrials.gov with International Atomic Energy Agency as lead sponsor.

NCT NCT00864331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00864331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
Lead sponsor
International Atomic Energy Agency
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2012
Enrollment
251 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer